← Study Library
RCT · 2005
Strongcounts toward this tierPharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium
Modi NB, Kell S, Simon M, Vargas R · Journal of Clinical Pharmacology
Strongcounts toward this tier
The specific interaction test behind the label: oral PPS at the licensed dose left R- and S-warfarin concentrations, half-lives, prothrombin time, partial thromboplastin time and INR unchanged. Adverse events were mild and mostly attributable to the warfarin titration.
- Population
- Healthy subjects titrated on warfarin to an INR of 1.4–1.8
- Intervention
- Oral PPS 100 mg every 8 hours for 7 days on top of the titrated warfarin dose
- Comparator
- Placebo on top of the titrated warfarin dose
- Limitations
- Oral PPS only — the route with negligible systemic absorption — so the absence of an interaction cannot be carried across to injected PPS, which measurably prolongs clotting times on its own; healthy volunteers at a low target INR over one week.
Cited by
1 entry references this study
- Pentosan polysulfate (PPS)PROM.
Peptides → Clinically studied